This companion to Braunwald's Heart Disease equips you with all of today's most effective therapeutic guidelines and management solutions for the full range of heart disease patients. It reflects the most recent standards for drug management as well as the latest in new technologies. Reorganized to mirror your changing practice, each cardiovascular-problem-based section offers a chapter on pharmacologic treatment (with a minimum of pathophysiology)…a chapter on catheter-based or minimally invasive interventions…and a discussion of surgical options. You'll also find a brand-new chapter on gene therapy and stem cell therapy, plus new chapters on many other rapidly developing areas of practice. The result is an outstanding single-volume source for state-of-the-art, clinically oriented guidance on both common and unusual areas of cardiovascular treatment.
Reviews
"This multi-author book contains comprehensive information on cardiovascular therapeutics, a rapidly changing field. Dr Antman is to be congratulated for bringing together 112 experts in their respective fields who collectively contribute 55 chapters. All aspects of cardiovascular therapeutics are covered." — Circulation
Features
Features an emphasis on user-friendly, clinically relevant information in a format that is fast and easy-to-access.
Extensive details of all interventions are highlighted in text, tables, and crisp, high-quality illustrations.
Provides an up-to-date source for interpretation of clinical data, drug interactions, available devices, and indications for therapy
What's New
Addresses pharmacological, interventional, and surgical management approaches for each type of cardiovascular disease, putting advice on the full range of therapeutic options at your disposal.
Keeps you current with brand-new chapters on gene therapy and stem cell therapy • unstable and chronic stable angina • management of unstable angina and non-ST-elevation myocardial infarction • devices for heart failure and arrhythmias • prevention of ischemic disease • the regulatory approval process for new cardiovascular drugs and devices • and more.
Delivers a fully revised section on "Heart Failure" that explores cardiac resynchronization therapy, surgical interventions, ambulatory management, hospital management, and cardiac transplantation and circulatory support devices.
Offers a completely updated section on "Other Cardiovascular Conditions" that addresses issues such as pharmacologic treatment of cardiovascular disease during pregnancy • care for adults with congenital heart disease • treatment of primary pulmonary hypertension • prevention and treatment of infective endocarditis • treatment of pericardial disease • and rehabilitation of the patient with cardiovascular disease.
Reflects a new emphasis on the role of diet and exercise in the management of cardiovascular problems in conformity with ACC/AHA/ESC guidelines
Table of Contents:
I. Decision Making and Therapeutic Strategies in Cardiovascular Medicine
1. Tools for Assessment of Cardiovascular Tests and Therapies
2. Pharmacologic Principles
3. Gene Therapy/Stem Cell Therapy for Cardiovascular Disorders
4. The Process of Regulatory Approval of New Cardiovascular Drugs and Devices
II. Ischemic Heart Disease
5. Pharmacologic Options for Treatment of Ischemic Disease
6. Mechanical Approaches to Percutaneous Coronary Intervention
7. DES, thrombus extraction, embolization protection devices
8. Ischemic Heart Disease: Surgical Options-A Cardiology Perspective
9. Coronary Artery Bypass Surgery: A Surgical Perspective
10. Primary Prevention of Ischemic Heart Disease
11. Management of Unstable Angina and Non-ST- Elevation Myocardial Infarction
12. ST-Elevation Myocardial Infarction
13. Chronic Angina: Stable
III. Heart Failure
14. Principles of Pharmacologic Management of Chronic Heart Failure
15. Cardiac Resynchronization Therapy
16. Surgical Interventions for Heart Failure
17. Ambulatory Management of Heart Failure
18. Hospital Management of Heart Failure
19. Cardiac Transplantation and Circulatory Support Devices
IV. Arrhythmias and Conduction Disturbances
20. Clinical Pharmacology of Antiarrhythmic Drugs
21. Nonpharmacologic Treatment of Tachyarrhythmias
22. Implantable Devices for the Electrical Management of Heart Disease: Overview of Indications for Therapy and Selected Advances
23. Surgical Options for Treatment of Arrhythmias
24. Acute and Chronic Pharmacologic Management of Supraventricular Tachyarrhythmias
25. AF - A Comprehensive Approach
26. Malignant Ventricular Arrhythmias
V. Dyslipoproteinemias/Atherosclerosis
27. Dyslipoproteinemias/ Atherosclerosis: Overview of Pathology and Management Strategies
28. Dyslipoproteinemias/ Atherosclerosis: Dietary Therapy
29. Dyslipoproteinemias/ Atherosclerosis: Pharmacologic Therapy
30. The Steps Beyond Diet and Drug Therapy for Severe Hypercholesterolemia
VI. Hypertension
31. Antihypertensive Therapy
32. Lifestyle Modification in the Treatment of Hypertension
33. Pharmacologic Treatment of Hypertension
34. Secondary Hypertension: Endocrine Causes
35. Secondary Hypertension: Renal Vascular Causes
36. Treatment of Hypertension in the Patient with Cardiovascular Disease
37. Treatment of Hypertension in Patients with Renal Disease
38. Refractory Hypertension
39. Hypertensive Emergencies
40. Hypertension in Pregnancy and in Children
VII. Other Cardiovascular Conditions
41. Pharmacologic Options for Treating Cardiovascular Disease during Pregnancy
42. Care for Adults with Congenital Heart Disease
43. Treatment of Primary Pulmonary Hypertension
44. Prevention and Treatment of Infective Endocarditis
45. Treatment of Pericardial Disease
46. The Timing of Valve Surgery
47. Surgical Therapy for Valvular Heart Disease
48. Rehabilitation of the Patient with Cardiovascular Disease
Appendices
1. Cardiovascular Drugs
2. Cardiovascular Devices
O autorze:
By Elliott M. Antman, MD, Professor of Medicine, Cardiology, Harvard Medical School, Department of Medicine, Brigham and Women's Hospital, Boston, MA
